Anthony leads global teams accountable for driving the quality strategy, systems, and performance across the internal and external manufacturing, suppliers, and distribution network. In addition to corporate quality functions and strategy, Anthony oversees global teams responsible for the pharmaceutical quality management system, issues management teams, global marketing company quality, Alexion rare disease unit central quality, quality business performance/LEAN, and digital strategy for quality. Before joining AstraZeneca, Anthony held operations leadership positions in global strategic, overseas, and regional/site roles in manufacturing, quality, and compliance roles at Amgen, Biogen, Catalent Pharma Solutions, and Johnson & Johnson.